ZA934882B - Vaccines against aujeszkyu's disease and other animal diseases containing pseudorabies virus mutants - Google Patents
Vaccines against aujeszkyu's disease and other animal diseases containing pseudorabies virus mutantsInfo
- Publication number
- ZA934882B ZA934882B ZA934882A ZA934882A ZA934882B ZA 934882 B ZA934882 B ZA 934882B ZA 934882 A ZA934882 A ZA 934882A ZA 934882 A ZA934882 A ZA 934882A ZA 934882 B ZA934882 B ZA 934882B
- Authority
- ZA
- South Africa
- Prior art keywords
- disease
- pseudorabies virus
- animal diseases
- pct
- aujeszkyu
- Prior art date
Links
- 208000031295 Animal disease Diseases 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000035772 mutation Effects 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000009305 pseudorabies Diseases 0.000 abstract 2
- 101000686824 Enterobacteria phage N4 Virion DNA-directed RNA polymerase Proteins 0.000 abstract 1
- 101000644628 Escherichia phage Mu Tail fiber assembly protein U Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108010059485 brain synaptic membrane glycoprotein gp 50 Proteins 0.000 abstract 1
- 101150030521 gI gene Proteins 0.000 abstract 1
- 101150118312 gp63 gene Proteins 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92202096 | 1992-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA934882B true ZA934882B (en) | 1994-02-03 |
Family
ID=8210764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA934882A ZA934882B (en) | 1992-07-09 | 1993-07-07 | Vaccines against aujeszkyu's disease and other animal diseases containing pseudorabies virus mutants |
Country Status (18)
Country | Link |
---|---|
US (1) | US5674500A (el) |
EP (1) | EP0654086B1 (el) |
JP (1) | JPH07509127A (el) |
KR (1) | KR100341994B1 (el) |
CN (1) | CN1124159C (el) |
AT (1) | ATE189000T1 (el) |
AU (1) | AU684252B2 (el) |
CA (1) | CA2139507C (el) |
DE (1) | DE69327656T2 (el) |
DK (1) | DK0654086T3 (el) |
ES (1) | ES2143507T3 (el) |
HU (1) | HU220099B (el) |
NZ (1) | NZ254267A (el) |
PL (1) | PL174219B1 (el) |
RU (1) | RU2158308C2 (el) |
TW (1) | TW289731B (el) |
WO (1) | WO1994001573A1 (el) |
ZA (1) | ZA934882B (el) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2290906C (en) * | 1991-06-06 | 2003-04-01 | Stichting Centraal Diergeneeskundig Instituut | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
US6007825A (en) * | 1991-12-23 | 1999-12-28 | American Cyanamid Company | Serpulina hyodysenteriae vaccine comprising a tly gene mutant |
US7223411B1 (en) * | 1992-07-31 | 2007-05-29 | Dana-Farber Cancer Institute | Herpesvirus replication defective mutants |
US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6773908B1 (en) * | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6380376B1 (en) * | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
AU696336B2 (en) * | 1993-03-19 | 1998-09-10 | Cantab Pharmaceuticals Research Limited | Defective mutant non-retroviral virus (e.g. HSV) as vaccine |
EP0659885A1 (en) * | 1993-12-21 | 1995-06-28 | Akzo Nobel N.V. | Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
EP0693551A1 (en) | 1994-07-18 | 1996-01-24 | Akzo Nobel N.V. | gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US6399354B1 (en) | 1998-07-31 | 2002-06-04 | President And Fellows Of Harvard College | Replication-competent virus expressing a detectable fusion protein |
CA2366072C (en) * | 1999-03-08 | 2007-07-10 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Prrsv vaccines |
PT2251419E (pt) * | 1999-04-22 | 2012-09-03 | Us Agriculture | Vacina contra a síndrome reprodutiva e respiratória porcina com base no isolado ja-142 |
AU2003297062A1 (en) * | 2002-12-11 | 2004-06-30 | University Of Massachusetts | METHOD OF INTRODUCING siRNA INTO ADIPOCYTES |
CA2571452A1 (en) * | 2004-06-18 | 2006-01-26 | Regents Of The University Of Minnesota | Identifying virally infected and vaccinated organisms |
US7632636B2 (en) * | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
US8110390B2 (en) | 2005-06-24 | 2012-02-07 | Regents Of The University Of Minnesota | PRRS viruses, infectious clones, mutants thereof, and methods of use |
CN101081298A (zh) * | 2007-06-26 | 2007-12-05 | 陈少莺 | 一种猪伪狂犬病新型亚单位疫苗制备方法 |
EP2328612A4 (en) * | 2008-08-25 | 2012-11-14 | Boehringer Ingelheim Vetmed | VACCINE AGAINST HIGH PATHOGENIC DISEASED LATE LIVESTOCK (PRRS) |
CN101457215B (zh) * | 2008-12-01 | 2010-11-17 | 华中农业大学 | 重组猪伪狂犬病毒-猪繁殖与呼吸综合征病毒-猪圆环病毒基因工程毒株及应用 |
AR078253A1 (es) * | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
EP2675476B1 (en) | 2011-02-17 | 2015-09-16 | Boehringer Ingelheim Vetmedica GmbH | Commercial scale process for production of prrsv |
EA038012B1 (ru) | 2011-02-17 | 2021-06-23 | Бёрингер Ингельхайм Ветмедика Гмбх | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
EP2737058A1 (en) | 2011-07-29 | 2014-06-04 | Boehringer Ingelheim Vetmedica GmbH | INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
CN105073130A (zh) | 2013-03-15 | 2015-11-18 | 勃林格殷格翰动物保健公司 | 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法 |
CN104250640A (zh) * | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN111560355A (zh) * | 2015-03-20 | 2020-08-21 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE60799T1 (de) * | 1985-07-29 | 1991-02-15 | Upjohn Co | Virus-impfstoff. |
US5352575A (en) * | 1985-10-04 | 1994-10-04 | The Upjohn Company | Pseudorabies virus protein |
US4999296A (en) * | 1986-04-29 | 1991-03-12 | Novagene, Inc. | Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same |
NL8902087A (nl) * | 1989-08-17 | 1991-03-18 | Stichting Tech Wetenschapp | Niet-natuurlijk voorkomend pseudorabiesvirus en vaccins die dit bevatten. |
EP0550553B1 (en) * | 1990-09-25 | 2000-07-12 | Cantab Pharmaceuticals Research Limited | Viral defective vaccine produced by transcomplementing cell line |
JPH07500972A (ja) * | 1992-07-30 | 1995-02-02 | アクゾ・ノベル・エヌ・ベー | 非放出性ヘルペスウイルス生ワクチン |
-
1993
- 1993-07-02 TW TW82105279A patent/TW289731B/zh active
- 1993-07-07 ZA ZA934882A patent/ZA934882B/xx unknown
- 1993-07-08 PL PL93307049A patent/PL174219B1/pl not_active IP Right Cessation
- 1993-07-08 CA CA 2139507 patent/CA2139507C/en not_active Expired - Fee Related
- 1993-07-08 US US08/373,325 patent/US5674500A/en not_active Expired - Fee Related
- 1993-07-08 HU HU9500039A patent/HU220099B/hu not_active IP Right Cessation
- 1993-07-08 AT AT93916297T patent/ATE189000T1/de not_active IP Right Cessation
- 1993-07-08 RU RU95105518A patent/RU2158308C2/ru not_active IP Right Cessation
- 1993-07-08 DK DK93916297T patent/DK0654086T3/da active
- 1993-07-08 EP EP19930916297 patent/EP0654086B1/en not_active Expired - Lifetime
- 1993-07-08 KR KR1019950700064A patent/KR100341994B1/ko not_active IP Right Cessation
- 1993-07-08 NZ NZ254267A patent/NZ254267A/en unknown
- 1993-07-08 DE DE69327656T patent/DE69327656T2/de not_active Expired - Fee Related
- 1993-07-08 WO PCT/NL1993/000146 patent/WO1994001573A1/en active IP Right Grant
- 1993-07-08 AU AU45898/93A patent/AU684252B2/en not_active Ceased
- 1993-07-08 ES ES93916297T patent/ES2143507T3/es not_active Expired - Lifetime
- 1993-07-08 JP JP6503188A patent/JPH07509127A/ja active Pending
- 1993-07-09 CN CN93108005A patent/CN1124159C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2139507A1 (en) | 1994-01-20 |
PL174219B1 (pl) | 1998-06-30 |
AU684252B2 (en) | 1997-12-11 |
CN1086143A (zh) | 1994-05-04 |
AU4589893A (en) | 1994-01-31 |
HU9500039D0 (en) | 1995-03-28 |
CA2139507C (en) | 2005-04-19 |
HUT70986A (en) | 1995-11-28 |
RU95105518A (ru) | 1997-03-27 |
HU220099B (hu) | 2001-10-28 |
DE69327656D1 (de) | 2000-02-24 |
KR100341994B1 (ko) | 2002-11-30 |
DK0654086T3 (da) | 2000-06-13 |
JPH07509127A (ja) | 1995-10-12 |
EP0654086B1 (en) | 2000-01-19 |
ES2143507T3 (es) | 2000-05-16 |
EP0654086A1 (en) | 1995-05-24 |
ATE189000T1 (de) | 2000-02-15 |
TW289731B (el) | 1996-11-01 |
RU2158308C2 (ru) | 2000-10-27 |
WO1994001573A1 (en) | 1994-01-20 |
NZ254267A (en) | 1996-08-27 |
DE69327656T2 (de) | 2000-08-03 |
PL307049A1 (en) | 1995-05-02 |
CN1124159C (zh) | 2003-10-15 |
US5674500A (en) | 1997-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW289731B (el) | ||
NZ309659A (en) | Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses | |
DE69529748D1 (de) | Polynukleotide vakzine gegen den papilloma virus | |
Rotman et al. | IL‐12 eliminates the Th‐2 dependent protective immune response of mice to larval Strongyloides stercoralis | |
PH25776A (en) | Pseudorabies virus mutants incapable of producing glycoprotein x | |
DK0573614T3 (da) | Svækket, genteknologisk fremstillet pseudorabiesvirus S-PRV-155 samt anvendelse heraf | |
UA49814C2 (uk) | Композиція, яка містить антиген вірусу папіломи, спосіб лікування цервікального раку, спосіб лікування гострокінцевої кондиломи | |
AU4951196A (en) | Vaccines for plague | |
UA40571C2 (uk) | Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена | |
DE69333751D1 (de) | Nicht-verbreitendes lebendes herpesvirusvakzin | |
Rosado-Vallado et al. | Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana | |
HUT69794A (en) | New bacterium causing poultry disease and vaccine derived thereof | |
EP0626008A4 (en) | Vaccine containing acemannan as an adjuvant. | |
ATE181104T1 (de) | Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung | |
WO2002072013A8 (en) | Method of treating malignancies through induction of blood immune responses | |
EP0612532A3 (en) | Canine coronavirus vaccine from feline enteric coronavirus | |
AU653861B2 (en) | Respiratory disease vaccine for cats | |
Bungiro Jr et al. | Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge | |
ES2105984A1 (es) | Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. | |
SE9401596D0 (sv) | New compounds | |
UA50800C2 (uk) | Спосіб вакцинації тварин від інфекційних захворювань | |
Knopf et al. | Interleukin-12 as an Adjuvant for an |